FENC stock forecast
Our latest prediction for Fennec Pharmaceuticals, Inc.'s stock price was made on the March 28, 2018 when the stock price was at 12.10$.
In the short term (2weeks), FENC's stock price should underperform the market by -2.47%. During that period the price should oscillate between -10.81% and +10.13%.
In the medium term (3months), FENC's stock price should outperform the market by 2.91%. During that period the price should oscillate between -22.06% and +30.17%.Get email alerts
About Fennec Pharmaceuticals, Inc.
Fennec Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.52$ per share.
The book value per share is 1.31$
Three months stock forecastMarch 28, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|